The TrumpRx.gov website helps uninsured & cash-paying patients save on 40+ brand drugs. Here's the complete list of discounted drugs.

All 16 drug companies that inked deals with the Trump administration over the past few months still raised some of their prices for 2026.

The Centers for Medicare & Medicaid Services has announced the selection of 15 prescription drugs for the third cycle of the Medicare Drug Price Negotiation Program. These are high-cost drugs covered under Medicare Part D and, for the first time, drugs payable under Medicare Part B.

CMS names medications 2028 for Medicare price negotiation, including Trulicity and Biktarvy, targeting high-cost drugs in Parts B and D.

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into effect until 2028.